A role for AID in chromosome translocations between c-myc and the IgH variable region

被引:69
作者
Dorsett, Yair
Robbiani, Davide F.
Jankovic, Mila
Reina-San-Martin, Bernardo
Eisenreich, Thomas R.
Nussenzweig, Michel C. [1 ]
机构
[1] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA
[2] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA
[3] ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France
关键词
D O I
10.1084/jem.20070884
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chromosome translocations between oncogenes and the region spanning the immunoglobulin ( Ig) heavy chain ( IgH) variable ( V), diversity ( D), and joining ( J) gene segments ( Ig V-J(H) region) are found in several mature B cell lymphomas in humans and mice. The breakpoints are frequently adjacent to the recombination signal sequences targeted by recombination activating genes 1 and 2 during antigen receptor assembly in pre-B cells, suggesting that these translocations might be the result of aberrant V( D) J recombination. However, in mature B cells undergoing activation-induced cytidine deaminase ( AID)-dependent somatic hypermutation ( SHM), duplications or deletions that would necessitate a double-trand break make up 6% of all the Ig V-J(H) region -associated somatic mutations. Furthermore, DNA breaks can be detected at this locus in B cells undergoing SHM. To determine whether SHM might induce c-myc to Ig V-J(H) translocations, we searched for such events in both interleukin ( IL) 6 transgenic ( IL-6 tg) and AID(-/)-IL-6 tg mice. Here, we report that AID is required for c-myc to Ig V-J H translocations induced by IL-6.
引用
收藏
页码:2225 / 2232
页数:8
相关论文
共 69 条
[1]   TRANSCRIPTIONALLY ACTIVE DNA REGION THAT REARRANGES FREQUENTLY IN MURINE LYMPHOID TUMORS [J].
ADAMS, JM ;
GERONDAKIS, S ;
WEBB, E ;
MITCHELL, J ;
BERNARD, O ;
CORY, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (22) :6966-6970
[2]   Atm-deficient mice: A paradigm of ataxia telangiectasia [J].
Barlow, C ;
Hirotsune, S ;
Paylor, R ;
Liyanage, M ;
Eckhaus, M ;
Collins, F ;
Shiloh, Y ;
Crawley, JN ;
Ried, T ;
Tagle, D ;
WynshawBoris, A .
CELL, 1996, 86 (01) :159-171
[3]   Activation-induced deaminase: controversies and open questions [J].
Barreto, VM ;
Ramiro, AR ;
Nussenzweig, MC .
TRENDS IN IMMUNOLOGY, 2005, 26 (02) :90-96
[4]   Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints [J].
Bartkova, Jirina ;
Rezaei, Nousin ;
Liontos, Michalis ;
Karakaidos, Panagiotis ;
Kletsas, Dimitris ;
Issaeva, Natalia ;
Vassiliou, Leandros-Vassilios F. ;
Kolettas, Evangelos ;
Niforou, Katerina ;
Zoumpourlis, Vassilis C. ;
Takaoka, Munenori ;
Nakagawa, Hiroshi ;
Tort, Frederic ;
Fugger, Kasper ;
Johansson, Fredrik ;
Sehested, Maxwell ;
Andersen, Claus L. ;
Dyrskjot, Lars ;
Orntoft, Torben ;
Lukas, Jiri ;
Kittas, Christos ;
Helleday, Thomas ;
Halazonetis, Thanos D. ;
Bartek, Jiri ;
Gorgoulis, Vassilis G. .
NATURE, 2006, 444 (7119) :633-637
[5]   Histone H2AX: A dosage-dependent suppressor of oncogenic translocations and tumors [J].
Bassing, CH ;
Suh, H ;
Ferguson, DO ;
Chua, KF ;
Manis, J ;
Eckersdorff, M ;
Gleason, M ;
Bronson, R ;
Lee, C ;
Alt, FW .
CELL, 2003, 114 (03) :359-370
[6]   The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line [J].
Bemark, M ;
Neuberger, MS .
ONCOGENE, 2000, 19 (30) :3404-3410
[7]   Chromosome translocations in multiple myeloma [J].
Bergsagel, PL ;
Kuehl, WM .
ONCOGENE, 2001, 20 (40) :5611-5622
[8]   Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice [J].
Borghesani, PR ;
Alt, FW ;
Bottaro, A ;
Davidson, L ;
Aksoy, S ;
Rathbun, GA ;
Roberts, TM ;
Swat, W ;
Segal, RA ;
Gu, YS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3336-3341
[9]   DNA double-strand breaks: Prior to but not sufficient in targeting hypermutation [J].
Bross, L ;
Muramatsu, M ;
Kinoshita, K ;
Honjo, T ;
Jacobs, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (09) :1187-1192
[10]  
Bross Linda, 2003, Clin Dev Immunol, V10, P83, DOI 10.1080/10446670310001626571